
Cutera CUTR
Quarterly report 2024-Q3
added 11-12-2024
Country |
|
IPO year |
2004 |
Industry |
Medical devices |
Stock Exchange |
NASDAQ GLOBAL |
Shares |
19.9 M |
Market Cap[1] |
$ 1.99 M |
EBITDA (LTM) |
$ -91.6 M |
P/E (LTM) |
- |
P/S (LTM) |
0.01 |
EPS (LTM) |
-7.07 |
Other stocks of industry "Medical devices"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Apyx Medical Corporation
APYX
|
$ 3.86 | -3.26 % | $ 134 M | Nasdaq Global Select Market | ||
|
BioSig Technologies
BSGM
|
- | 37.08 % | $ 85.7 M | Nasdaq Global Select Market | ||
|
Abiomed
ABMD
|
- | - | $ 17.2 B | Nasdaq Global Select Market,SPB | ||
|
GenMark Diagnostics, Inc.
GNMK
|
- | - | $ 1.77 B | Nasdaq Global Select Market | ||
|
Lianluo Smart Limited
LLIT
|
- | 24.59 % | $ 44.8 M | Nasdaq Global Select Market | ||
|
Eargo
EAR
|
- | - | $ 10.2 M | Nasdaq Global Select Market,SPB | ||
|
Obalon Therapeutics, Inc.
OBLN
|
- | -5.86 % | $ 30.6 M | Nasdaq Capital Market | ||
|
Bio-Rad Laboratories
BIO
|
$ 307.92 | -1.93 % | $ 8.69 B | NYSE,SPB | ||
|
Apollo Endosurgery
APEN
|
- | - | $ 475 M | Nasdaq Global Market | ||
|
Acutus Medical
AFIB
|
- | -26.83 % | $ 2.62 M | Nasdaq Global Select Market | ||
|
Bruker Corporation
BRKR
|
$ 45.13 | -2.67 % | $ 6.72 K | Nasdaq Global Select Market,SPB | ||
|
Allied Healthcare Products
AHPI
|
- | 3.58 % | $ 2.21 M | Nasdaq Capital Market | ||
|
Conformis
CFMS
|
- | - | $ 16.4 M | Nasdaq Capital Market | ||
|
Abbott Laboratories
ABT
|
$ 125.1 | 1.48 % | $ 218 B | NYSE,SPB | ||
|
Boston Scientific Corporation
BSX
|
$ 92.34 | 0.64 % | $ 136 B | NYSE,SPB | ||
|
CryoLife, Inc.
CRY
|
- | -4.14 % | $ 702 M | NYSE,SPB | ||
|
EDAP TMS S.A.
EDAP
|
$ 2.56 | 8.94 % | $ 95.5 M | Nasdaq Global Market | ||
|
Invacare Corporation
IVC
|
- | - | $ 24.7 M | NYSE | ||
|
Cardiovascular Systems
CSII
|
- | 0.15 % | $ 844 M | Nasdaq Global Select Market,SPB | ||
|
IRIDEX Corporation
IRIX
|
$ 0.92 | -4.72 % | $ 14.8 M | Nasdaq Global Select Market | ||
|
CHF Solutions, Inc.
CHFS
|
- | 1.15 % | $ 34.5 M | Nasdaq Capital Market | ||
|
IRadimed Corporation
IRMD
|
$ 96.35 | -1.06 % | $ 1.22 B | Nasdaq Global Select Market | ||
|
OrthoPediatrics Corp.
KIDS
|
$ 17.7 | -3.46 % | $ 408 M | Nasdaq Global Select Market,SPB | ||
|
Soliton, Inc.
SOLY
|
- | -1.42 % | $ 435 M | Nasdaq Global Select Market | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
- | -1.98 % | $ 98.3 M | Nasdaq Capital Market | ||
|
Itamar Medical Ltd.
ITMR
|
- | 0.03 % | $ 1.58 B | Nasdaq Global Select Market | ||
|
Misonix, Inc.
MSON
|
- | - | $ 462 M | Nasdaq Global Select Market | ||
|
Neovasc
NVCN
|
- | - | $ 111 M | Nasdaq Capital Market | ||
|
LivaNova PLC
LIVN
|
$ 62.79 | -1.82 % | $ 3.41 B | Nasdaq Global Select Market | ||
|
Pulmonx Corporation
LUNG
|
$ 2.53 | 0.86 % | $ 99 M | Nasdaq Global Select Market | ||
|
Dynatronics Corporation
DYNT
|
- | 14.99 % | $ 929 K | Nasdaq Capital Market | ||
|
Intersect ENT, Inc.
XENT
|
- | - | $ 955 M | Nasdaq Global Market | ||
|
InMode Ltd.
INMD
|
$ 14.56 | 0.76 % | $ 1.15 B | Nasdaq Global Select Market,SPB | ||
|
Cognyte Software Ltd.
CGNT
|
$ 9.88 | 0.05 % | $ 709 M | Nasdaq Global Select Market,SPB | ||
|
Myomo
MYO
|
$ 1.06 | -1.85 % | $ 7.47 M | NYSE American | ||
|
Second Sight Medical Products
EYES
|
- | -0.97 % | $ 54.4 M | Nasdaq Capital Market | ||
|
Integra LifeSciences Holdings Corporation
IART
|
$ 13.41 | -4.56 % | $ 1.03 B | Nasdaq Global Select Market,SPB | ||
|
NuVasive
NUVA
|
- | - | $ 2.07 B | Nasdaq Global Select Market,SPB | ||
|
Align Technology
ALGN
|
$ 165.15 | 0.78 % | $ 12.4 B | Nasdaq Global Select Market,SPB | ||
|
Accuray Incorporated
ARAY
|
$ 1.07 | -3.18 % | $ 110 M | Nasdaq Global Select Market | ||
|
Avinger
AVGR
|
- | -20.74 % | $ 369 K | Nasdaq Capital Market | ||
|
ClearPoint Neuro
CLPT
|
$ 12.81 | -1.23 % | $ 346 M | Nasdaq Capital Market | ||
|
Orthofix Medical
OFIX
|
$ 15.51 | -1.27 % | $ 591 M | Nasdaq Global Select Market,SPB | ||
|
FONAR Corporation
FONR
|
$ 14.86 | -0.03 % | $ 97.4 M | Nasdaq Capital Market | ||
|
AxoGen
AXGN
|
$ 30.33 | 1.15 % | $ 1.34 B | Nasdaq Capital Market,SPB | ||
|
Axonics Modulation Technologies
AXNX
|
- | - | $ 3.31 B | Nasdaq Global Select Market,SPB | ||
|
GBS
GBS
|
- | -0.57 % | $ 7.12 M | Nasdaq Global Market | ||
|
CONMED Corporation
CNMD
|
$ 40.78 | 2.33 % | $ 1.26 B | NYSE,SPB | ||
|
LENSAR
LNSR
|
$ 11.48 | -0.17 % | $ 132 M | Nasdaq Capital Market |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.